XML 91 R76.htm IDEA: XBRL DOCUMENT v3.25.3
Share-based Payments (Summary of Share Unit Activity) (Details)
9 Months Ended
Sep. 30, 2025
$ / shares
shares
Performance Share Units (Performance Conditions) | Equity-classified  
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Outstanding beginning balance, Shares | shares 450,175
Granted, Shares | shares 153,439
Vested and settled, Shares | shares (132,018)
Forfeited, Shares | shares (4,155)
Outstanding ending balance, Shares | shares 467,441
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Outstanding beginning balance, Weighted average grant date fair value (usd per share) | $ / shares $ 64.73
Granted, Weighted average grant date fair value (usd per share) | $ / shares 99.88
Vested and settled, Weighted average grant date fair value (usd per share) | $ / shares 58.74
Forfeited, Weighted average grant date fair value (usd per share) | $ / shares 73.41
Outstanding ending balance, Weighted average grant date fair value (usd per share) | $ / shares $ 77.88
Performance Share Units (Market Conditions) | Equity-classified  
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Outstanding beginning balance, Shares | shares 268,954
Granted, Shares | shares 153,208
Vested and settled, Shares | shares 0
Forfeited, Shares | shares (2,870)
Outstanding ending balance, Shares | shares 419,292
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Outstanding beginning balance, Weighted average grant date fair value (usd per share) | $ / shares $ 105.53
Granted, Weighted average grant date fair value (usd per share) | $ / shares 151.41
Vested and settled, Weighted average grant date fair value (usd per share) | $ / shares 0
Forfeited, Weighted average grant date fair value (usd per share) | $ / shares 125.54
Outstanding ending balance, Weighted average grant date fair value (usd per share) | $ / shares $ 122.16
Restricted Share Units | Equity-classified  
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Outstanding beginning balance, Shares | shares 607,805
Granted, Shares | shares 479,032
Vested and settled, Shares | shares (283,613)
Forfeited, Shares | shares (29,704)
Outstanding ending balance, Shares | shares 773,520
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Outstanding beginning balance, Weighted average grant date fair value (usd per share) | $ / shares $ 66.00
Granted, Weighted average grant date fair value (usd per share) | $ / shares 98.26
Vested and settled, Weighted average grant date fair value (usd per share) | $ / shares 63.30
Forfeited, Weighted average grant date fair value (usd per share) | $ / shares 81.11
Outstanding ending balance, Weighted average grant date fair value (usd per share) | $ / shares $ 86.39
Deferred Share Units | Liability-classified  
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Outstanding beginning balance, Shares | shares 73,490
Granted, Shares | shares 606
Vested and settled, Shares | shares (2,245)
Forfeited, Shares | shares 0
Outstanding ending balance, Shares | shares 71,851
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Outstanding beginning balance, Weighted average grant date fair value (usd per share) | $ / shares $ 40.29
Granted, Weighted average grant date fair value (usd per share) | $ / shares 106.01
Vested and settled, Weighted average grant date fair value (usd per share) | $ / shares 67.40
Forfeited, Weighted average grant date fair value (usd per share) | $ / shares 0
Outstanding ending balance, Weighted average grant date fair value (usd per share) | $ / shares $ 40.00